|
RAD51L3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.571000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.246000E-01 |
| Normal-vs-Stage2 |
8.103400E-01 |
| Normal-vs-Stage3 |
1.126370E-01 |
| Normal-vs-Stage4 |
2.377200E-01 |
| Stage1-vs-Stage2 |
9.725800E-01 |
| Stage1-vs-Stage3 |
8.955600E-02 |
| Stage1-vs-Stage4 |
4.403400E-01 |
| Stage2-vs-Stage3 |
1.256810E-01 |
| Stage2-vs-Stage4 |
6.160800E-01 |
| Stage3-vs-Stage4 |
5.039800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.500200E-01 |
| Normal-vs-AfricanAmerican |
1.557210E-01 |
| Normal-vs-Asian |
6.320000E-01 |
| Caucasian-vs-AfricanAmerican |
4.132100E-02 |
| Caucasian-vs-Asian |
6.884200E-01 |
| AfricanAmerican-vs-Asian |
5.118600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.152600E-01 |
| Normal-vs-Female |
1.502720E-03 |
| Male-vs-Female |
3.7190999999992E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.988400E-01 |
| Normal-vs-Extreme_Weight |
5.338400E-02 |
| Normal-vs-Obese |
2.892800E-01 |
| Normal-vs-Extreme_Obese |
7.773400E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.663420E-01 |
| Normal_Weight-vs-Obese |
5.720800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.111400E-01 |
| Extreme_Weight-vs-Obese |
2.214000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.845400E-01 |
| Obese-vs-Extreme_Obese |
3.588600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.741000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.727010E-01 |
| Normal-vs-Age(61-80Yrs) |
1.578590E-01 |
| Normal-vs-Age(81-100Yrs) |
5.435700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.449800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.223200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.176990E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.400600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.491800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.195200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.702840E-01 |
| Normal-VS-Type2 PRCC |
2.984400E-01 |
| Normal-VS-KIRP CIMP |
8.187600E-02 |
| Normal-VS-Unclassified PRCC |
3.865600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.172000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.543750E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.018200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.836600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.689800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.363800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.670600E-01 |
| Normal-vs-N1 |
1.086990E-01 |
| Normal-vs-N2 |
5.110000E-01 |
| N0-vs-N1 |
8.644000E-02 |
| N0-vs-N2 |
5.116400E-01 |
| N1-vs-N2 |
8.375000E-01 |
|
|
